Free Trial

Amdocs (NASDAQ:DOX) Reaches New 52-Week Low - Here's Why

Amdocs logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Amdocs hit a new 52-week low around $63.21 (last $63.26) and was trading down about 1.7%; analysts maintain a consensus Moderate Buy with an average price target of $92.33 despite recent downgrades and lower targets.
  • The company posted an earnings beat with $1.81 EPS and $1.16B revenue for the quarter and issued Q2 2026 EPS guidance of $1.73–1.79 and FY 2026 guidance of $7.27–7.55.
  • Amdocs raised its quarterly dividend to $0.569 (annualized $2.28) for a ~3.6% yield, while institutional ownership remains very high (~92%), led by a large Q4 stake increase from Pzena.
  • MarketBeat previews the top five stocks to own by May 1st.

Amdocs Limited (NASDAQ:DOX - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Friday . The company traded as low as $63.21 and last traded at $63.2550, with a volume of 408695 shares trading hands. The stock had previously closed at $64.39.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on DOX. Wall Street Zen downgraded Amdocs from a "buy" rating to a "hold" rating in a research note on Saturday, March 21st. Barclays cut their price target on Amdocs from $111.00 to $92.00 and set an "overweight" rating for the company in a research note on Wednesday, February 4th. Weiss Ratings restated a "hold (c)" rating on shares of Amdocs in a research note on Tuesday, January 27th. Finally, Stifel Nicolaus lowered their price objective on Amdocs from $97.00 to $88.00 and set a "buy" rating on the stock in a research report on Wednesday, February 4th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $92.33.

Get Our Latest Analysis on DOX

Amdocs Trading Down 1.7%

The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The stock has a market capitalization of $6.83 billion, a PE ratio of 12.23, a PEG ratio of 1.17 and a beta of 0.46. The stock has a 50-day moving average price of $68.41 and a two-hundred day moving average price of $76.64.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.75 by $0.06. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The firm had revenue of $1.16 billion for the quarter, compared to analysts' expectations of $1.15 billion. During the same period in the previous year, the firm earned $1.66 EPS. The business's quarterly revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Tuesday, March 31st will be issued a $0.569 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a yield of 3.6%. This is a boost from Amdocs's previous quarterly dividend of $0.53. Amdocs's payout ratio is presently 43.91%.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Pzena Investment Management LLC lifted its holdings in Amdocs by 82.6% in the 4th quarter. Pzena Investment Management LLC now owns 12,037,015 shares of the technology company's stock worth $969,100,000 after purchasing an additional 5,443,766 shares in the last quarter. LSV Asset Management raised its holdings in shares of Amdocs by 0.8% during the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company's stock worth $296,159,000 after acquiring an additional 29,829 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Amdocs by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company's stock worth $253,786,000 after acquiring an additional 54,676 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Amdocs by 3.0% during the 3rd quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company's stock valued at $258,583,000 after acquiring an additional 91,900 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of Amdocs by 0.3% in the third quarter. Vanguard Group Inc. now owns 3,066,444 shares of the technology company's stock valued at $251,602,000 after purchasing an additional 9,207 shares in the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Company Profile

(Get Free Report)

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines